Please provide your email address to receive an email when new articles are posted on . Treatment responders demonstrated significant reductions in iron corrected T1 and liver fat content. Optimal ...
Perspectum, a global medical technology company advancing quantitative imaging for metabolic, liver and multi-organ health, ...
WASHINGTON & OXFORD, England--(BUSINESS WIRE)--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated steatohepatitis ...
Adding MRI to CT may improve the accuracy of detecting nonviable disappearing liver metastases than CT alone among patients with initially unresectable colorectal liver metastases. However, confirmed ...
Researchers from France have shown that hepatobiliary MR contrast agent uptake can predict survival in patients with resectable hepatocellular carcinoma (HCC) as well as 18 F-FDG PET/CT can. They ...
Treating liver cancer and liver metastases — cancer that has spread to the liver from elsewhere in the body — is challenging. Most patients are not candidates for surgery because there are many tumors ...
A new compound has been invented to bind to liver cells that are in the early stages of damage, thus making it easier to pick them up using MRI (magnetic resonance imaging). As reported in the journal ...
Researchers have developed a new MRI contrast dye that enables more accurate and safer detection of early-stage liver disease than currently approved agents. The new compound, called ProCA32.collagen1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback